Type 2 DM is associated with obesity and the secretion of proinflammatory cytokines by adipocytes (especially central obesity), which contribute to insulin resistance and β-cells injury (high levels of reactive oxygen species - ROS), compromising insulin action [10,31]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.